Health Care & Life Sciences » Biotechnology | InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. | Mutual Funds

Mutual Funds that own InVivo Therapeutics Holdings Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
IMS Capital Value Fund
20,010
0.26%
0
0.1%
03/31/2018
Vanguard Extended Market Index Fund
11,892
0.15%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
4,890
0.06%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
4,854
0.06%
0
0%
12/31/2017
Fidelity Nasdaq Composite Index
3,296
0.04%
0
0%
07/31/2018
Vanguard Balanced Index Fund
2,603
0.03%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
1,850
0.02%
0
0%
07/31/2018
Meeder Spectrum Fund
568
0.01%
297
0%
06/29/2018
iShares Core S&P Total US Stock Market ETF
509
0.01%
0
0%
09/06/2018
BlackRock Master Extended Market Index Series
231
0%
0
0%
01/31/2018

About InVivo Therapeutics Holdings

View Profile
Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.invivotherapeutics.com
Updated 07/08/2019
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.